Minji Lee

14PUBLICATIONS
37CO-AUTHORS
Clinical psychologyChemotherapyMolecular targetsPanel data analysisHuman impacts of climate change and human adaptation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 28, 2026
Psychometric Evaluation of the PRO-CTCAE Average Composite Score: Reliability, Responsiveness, Known-Groups Validity, and Sensitivity to Group Differences.

|May 27, 2026
Placebo Response in Phase II-III Symptom Intervention Studies: A Focus on Chemotherapy-Induced Peripheral Neuropathy and Associated Neuropathic Pain.

|Apr 29, 2026
Alliance A221805: Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II Study.

|Nov 13, 2025
Psychometric Properties and Interpretability of PRO-CTCAE® Average Composite Scores as a Summary Metric of Symptomatic Adverse Event Burden.

Minji K Lee, Sandra A Mitchell, Ethan Basch

|Nov 06, 2024
Identification of meaningful individual-level change thresholds for worsening on the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE®).

Minji K Lee, Sandra A Mitchell, Ethan Basch

|Mar 13, 2024
PRO-Angoff method for remote standard setting: establishing clinical thresholds for the upper digestive disease tool.

Minji K Lee, Mohamad K Abou Chaar, Shanda H Blackmon

Pageof 3

Frequent Collaborators

3 joint publications

Sandra A Mitchell

2 joint publications

Amylou C Dueck

2 joint publications

Kathryn Ruddy

2 joint publications

Gina L Mazza